Emily WyentSenior Director at Dantari, USASpeaker
Agenda Sessions
Next Generation Targeted High-Capacity Drug Conjugates for Higher Drug-to-Antibody Ratio
, 11:50View Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Next Generation Targeted High-Capacity Drug Conjugates for Higher Drug-to-Antibody Ratio